Literature DB >> 20789052

Agranulocytosis after Imipramine and Meprobamate.

T P Curran, E Barabas.   

Abstract

Entities:  

Year:  1961        PMID: 20789052      PMCID: PMC1953048          DOI: 10.1136/bmj.1.5221.257

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Meprobamate idiosyncrasy; report of a case and review of the literature.

Authors:  N D CHARKES
Journal:  AMA Arch Intern Med       Date:  1958-10

2.  Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy.

Authors:  L M MEYER; W L HEEVE; R W BERTSCHER
Journal:  N Engl J Med       Date:  1957-06-27       Impact factor: 91.245

3.  The treatment of depressive states with imipramine hydrochloride (tofranil).

Authors:  J T LEYBERG; J C DENMARK
Journal:  J Ment Sci       Date:  1959-10

4.  Agranulocytosis due to imipramine (tofranil).

Authors:  C E BIRD
Journal:  Can Med Assoc J       Date:  1960-05-14       Impact factor: 8.262

  4 in total
  3 in total

1.  MEPROBAMATE AND APLASTIC ANAEMIA.

Authors:  B W CROMIE
Journal:  Br Med J       Date:  1964-02-29

2.  IMIPRAMINE POISONING IN CHILDHOOD.

Authors:  H M GILES
Journal:  Br Med J       Date:  1963-10-05

3.  Reversible agranulocytosis due to meprobamate.

Authors:  S Ward; J Meecham
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.